Pathkey.AI Ltd (ASX:PKY)

Australia flag Australia · Delayed Price · Currency is AUD
0.0200
0.00 (0.00%)
Jan 22, 2026, 2:57 PM AEST
33.33%
Market Cap7.09M
Revenue (ttm)321.99K
Net Income (ttm)-1.45M
Shares Out354.60M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,644
Average Volume461,712
Open0.0200
Previous Close0.0200
Day's Range0.0200 - 0.0200
52-Week Range0.0140 - 0.0360
Beta0.92
RSI56.91
Earnings DateFeb 26, 2026

About Pathkey.AI

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathke... [Read more]

Sector Healthcare
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PKY
Full Company Profile

Financial Performance

In 2025, Pathkey.AI's revenue was 321,991, a decrease of -65.45% compared to the previous year's 932,076. Losses were -1.45 million, -53.75% less than in 2024.

Financial Statements